HomeInsightsStock Comparison

Epigral Ltd vs Primo Chemicals Ltd Stock Comparison

Epigral Ltd vs Primo Chemicals Ltd Stock Comparison

Last Updated on: Jul 02, 2025

Key Highlights

  • The Latest Trading Price of Epigral Ltd is ₹ 1829 as of 02 Jul 12:13.
  • The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of Primo Chemicals Ltd changed from 33.7 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of Primo Chemicals Ltd changed from ₹ 277.29 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of Epigral Ltd for the Mar '25 is ₹ 631.3 crore as compare to the Dec '24 revenue of ₹ 649.19 crore. This represent the decline of -2.76% The revenue of Primo Chemicals Ltd for the Mar '25 is ₹ 159.84 crore as compare to the Dec '24 revenue of ₹ 148.58 crore. This represent the growth of 7.58%.
  • The ebitda of Epigral Ltd for the Mar '25 is ₹ 177.05 crore as compare to the Dec '24 ebitda of ₹ 186.46 crore. This represent the decline of -5.05% The ebitda of Primo Chemicals Ltd for the Mar '25 is ₹ 28.38 crore as compare to the Dec '24 ebitda of ₹ 23.4 crore. This represent the growth of 21.28%.
  • The net profit of Epigral Ltd changed from ₹ 31.51 crore to ₹ 86.89 crore over 8 quarters. This represents a CAGR of 66.06% The net profit of Primo Chemicals Ltd changed from ₹ -3.72 crore to ₹ -1.12 crore over 8 quarters. This represents a CAGR of -45.13% .
  • The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of Primo Chemicals Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Epigral Ltd

  • Epigral Limited was erstwhile incorporated as Meghmani Finechem Limited in 2007, which engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
  • The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
  • The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
  • The Company is now among the leading players in India's chlor alkali industry.
  • In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About Primo Chemicals Ltd

  • Primo Chemicals Limited was erstwhile incorporated with the name 'Punjab Alkalies and Chemicals Limited' in December, 1975.
  • The Company later on changed the name from 'Punjab Alkalies and Chemicals Limited' to 'Primo Chemicals Limited' on December 19, 2022. The Company is the largest producer of Caustic Soda in Northern India and is operating two units based on Membrane Cell Technology in its Plant Complex at Naya Nangal, Distt.
  • Ropar Punjab (India).
  • It is primarily engaged in manufacturing of Caustic Soda Lye, Hydrochloric Acid, Liquid Chlorine, Sodium Hypochlorite, Hydrogen Gas, Stable Bleaching Powder, Caustic Soda Flakes and Aluminium Chloride. The Company has increased its Caustic production capacity from 300 TPA to 500 TPA resultant into combined manufacturing capacity of 165,000 TPA of Caustic Soda.

Epigral Ltd News Hub

News

Epigral AGM scheduled

Epigral announced that the Annual General Meeting(AGM) of the company will be held on 28 J...

Read more

06 Jun 2025 10:10

News

Epigral signs agreement to source 19.80 MW wind solar hybrid power

Epigral as on today 04 June 2025 has executed (I) Share Subscription and Shareholder's Agr...

Read more

04 Jun 2025 11:09

News

Board of Epigral recommends final dividend

Epigral announced that the Board of Directors of the Company at its meeting held on 5 May ...

Read more

05 May 2025 15:44

News

Epigral to discuss results

Epigral will hold a meeting of the Board of Directors of the Company on 5 May 2025. Powere...

Read more

23 Apr 2025 17:09

News

Epigral receives upgrade in credit ratings for LT bank facilities

Epigral announced that CRISIL Ratings has upgraded long term rating to CRISIL AA/Stable (f...

Read more

07 Mar 2025 12:57

News

Epigral edges higher after Crisil Ratings upgrades ratings to 'AA' with 'stable' outlook

The agency has reaffirmed its 'Crisil A1+' rating on the short-term bank facilities of Epi...

Read more

07 Mar 2025 14:21

Primo Chemicals Ltd News Hub

News

Primo Chemicals to hold board meeting

Primo Chemicals will hold a meeting of the Board of Directors of the Company on 30 May 202...

Read more

20 May 2025 14:06

News

Primo Chemicals to hold board meeting

Primo Chemicals will hold a meeting of the Board of Directors of the Company on 14 Februar...

Read more

03 Feb 2025 09:47

News

Primo Chemicals to conduct board meeting

Primo Chemicals will hold a meeting of the Board of Directors of the Company on 12 Novembe...

Read more

04 Nov 2024 11:04

News

Primo Chemicals to convene AGM

Primo Chemicals announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

31 Aug 2024 10:52

News

Primo Chemicals to discuss results

Primo Chemicals will hold a meeting of the Board of Directors of the Company on 12 August ...

Read more

02 Aug 2024 13:02

News

CARE Ratings revises Primo Chemicals rating outlook to 'negative’

The agency has also reaffirmed its ‘CARE A3’ rating on the short-term bank facilities of t...

Read more

11 Jun 2024 11:18

SWOT Analysis Of Primo Chemicals Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Epigral Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Primo Chemicals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Epigral Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Epigral Ltd and Primo Chemicals Ltd

Which company has a larger market capitalization, Epigral Ltd or Primo Chemicals Ltd?

Market cap of Epigral Ltd is 7,910 Cr while Market cap of Primo Chemicals Ltd is 634 Cr

What are the key factors driving the stock performance of Epigral Ltd and Primo Chemicals Ltd?

The stock performance of Epigral Ltd and Primo Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and Primo Chemicals Ltd?

As of July 2, 2025, the Epigral Ltd stock price is INR ₹1833.55. On the other hand, Primo Chemicals Ltd stock price is INR ₹26.17.

How do dividend payouts of Epigral Ltd and Primo Chemicals Ltd compare?

To compare the dividend payouts of Epigral Ltd and Primo Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions